Holen Sie sich die Stockscreener-App
7.59
0.26%
0.02
Handel nachbörslich:
7.47
-0.12
-1.58%
Xeris Biopharma Holdings Inc Aktie (XERS) Neueste Nachrichten
Johnson, director, sells Xeris Biopharma (XERS) shares for $786k - Investing.com
Johnson, director, sells Xeris Biopharma (XERS) shares for $786k By Investing.com - Investing.com Nigeria
Independent Director Dawn Halkuff Sold A Bunch Of Shares In Xeris Biopharma Holdings - simplywall.st
Can Xeris Biopharma Holdings Inc. expand its profit margins2025 Market Outlook & Precise Swing Trade Alerts - sundaytimes.kr
Tools to assess Xeris Biopharma Holdings Inc.’s risk profile2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Is Xeris Biopharma Holdings Inc. stock a good dividend stockQuarterly Portfolio Report & Stock Portfolio Risk Control - thegnnews.com
Will Xeris Biopharma Holdings Inc. benefit from macro trendsMarket Performance Recap & Capital Efficiency Focused Ideas - Newser
Insider Selling at Xeris Biopharma: A Signal or a Strategy? - AInvest
Xeris Biopharma Director Dawn Halkuff Sells 42,500 Shares at $7.28 Each. - AInvest
Xeris Biopharma (NASDAQ:XERS) Upgraded at HC Wainwright - Defense World
Dawn Halkuff sells Xeris Biopharma (XERS) shares worth $309k By Investing.com - Investing.com Nigeria
Dawn Halkuff sells Xeris Biopharma (XERS) shares worth $309k - Investing.com
Xeris Biopharma (NASDAQ:XERS) Raised to “Buy” at HC Wainwright - Defense World
How high can Xeris Biopharma Holdings Inc. stock goDollar Strength & Entry and Exit Point Strategies - Newser
Xeris Biopharma (NASDAQ:XERS) Coverage Initiated by Analysts at HC Wainwright - Defense World
Using Python tools to backtest Xeris Biopharma Holdings Inc. strategiesReal Time Stock Movement and Alerts - Newser
Xeris Biopharma (XERS) Upgraded to Buy: Here's Why - Yahoo Finance
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Xeris Biopharma Earns Buy Rating from HC Wainwright with $10 PT - AInvest
Can trapped investors hope for a rebound in Xeris Biopharma Holdings Inc.Momentum Prediction Based on AI Backtesting - Newser
How liquid is Xeris Biopharma Holdings Inc. stockSpeedy Gain Trade Picks - thegnnews.com
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Wyckoff Accumulation Phase Possible in Xeris Biopharma Holdings Inc.Potential Breakout Stock List Published This Week - beatles.ru
Bollinger Bands Show Potential Breakout in Xeris Biopharma Holdings Inc.Day Trading Signals With High Precision Reviewed - beatles.ru
How Xeris Biopharma Holdings Inc. stock performs during market volatilityForecast Model for Intraday Buy Signals - Newser
Xeris Biopharma Holdings Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2025 Earnings Call Transcript - Insider Monkey
Xeris Biopharma (NASDAQ:XERS) Sees Large Volume Increase Following Better-Than-Expected Earnings - Defense World
Xeris Biopharma (NASDAQ:XERS) Upgraded to “Strong-Buy” at Wall Street Zen - Defense World
Xeris Biopharma (XERS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - NewsBreak: Local News & Alerts
XERS (Xeris Biopharma Holdings) Momentum Rank : 3 (As of Aug. 08, 2025) - GuruFocus
XERS Crosses Above Average Analyst Target - Nasdaq
Xeris Biopharma Reports Record Q2 2025 Revenue, Raises Full-Year Guidance - AInvest
Xeris Biopharma: Q2 Earnings Snapshot - Connecticut Post
Xeris Biopharma (NASDAQ:XERS) Sets New 52-Week High Following Earnings Beat - Defense World
Xeris Biopharma Reports Strong Q2 2025 Results - TipRanks
Beyond the Balance Sheet: What SWOT Reveals About Xeris Biopharm - GuruFocus
Xeris raises 2025 revenue guidance to $280M–$290M following 49% Q2 growth, led by Recorlev - MSN
Xeris Biopharma Holdings, Inc. SEC 10-Q Report - TradingView
Transcript : Xeris Biopharma Holdings, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Xeris Biopharma Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Little Excitement Around Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Revenues - 富途牛牛
Xeris (XERS) Q2 Revenue Jumps 49% - The Motley Fool
Xeris Biopharma shares rise 24.23% premarket after beating Q2 revenue expectations and raising FY guidance. - AInvest
Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Xeris Biopharma Stock Soars 12.02% on Record Q2 Earnings - AInvest
Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance - BioSpace
Earnings Flash (XERS) Xeris Biopharma Posts Q2 Net Loss $0.01 a Share, vs. FactSet Est of $0.05 Loss - MarketScreener
Xeris Biopharma beats Q2 revenue expectations, raises FY guidance - MarketScreener
Mackenzie Financial Corp Has $780,000 Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Institutional scanner results for Xeris Biopharma Holdings Inc.Trade Flow Monitor with Volume Tracker - Newser
1.55%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):